ABSTRACT
In Alzheimer disease, therapies to improve the core symptoms and perhaps even slow disease progression include cholinesterase inhibitors, receptor agonists, anti-inflammatory drugs, and antioxidants. Neuroleptics, antiepileptics, and nondrug approaches are used to control and relieve complications such as delusions, hallucinations, paranoia, and agitated behavior. We outline a practical approach to the use of these therapies.
Footnotes
↵* Disciosure: Dr. Hanson has worked as a consultant for Novartis Pharmaceutical Corporation. Dr. Galvez-Jimenez has worked as a consultant for Novartis Pharmaceutical and for Athena Neurosciences and has received grant support from Novartis Pharmaceutical Corporation.
- Copyright © 2000 The Cleveland Clinic Foundation. All Rights Reserved.